Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

3.7K
Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
3.7K
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

945
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
945
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

941
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
941
Dialysis01:15

Dialysis

1.9K
Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
1.9K
Dialysis01:27

Dialysis

1.5K
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
1.5K
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

573
Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
573

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nuclear cell-free DNA on the loose: an early warning signal of ischemia-reperfusion injury in kidney transplantation.

Frontiers in immunology·2026
Same author

Early Postreperfusion Proteomics Reveal Divergent Inflammatory Responses in Kidney Transplantation With Implications on Outcomes.

Transplantation·2025
Same author

Comparing Computational Peritoneal Dialysis Models in Pigs and Patients.

Toxins·2025
Same author

[Acute kidney injury - prevention and treatment].

Lakartidningen·2025
Same author

Bimodal solutions in peritoneal dialysis: what can we expect from different glucose volumes added to the icodextrin bag? Data from a simulation procedure.

Journal of nephrology·2025
Same author

Computational modeling of peritoneal dialysis: An overview.

Mathematical biosciences and engineering : MBE·2025

Related Experiment Video

Updated: Feb 16, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

3.3K

Optimizing Automated Peritoneal Dialysis Using an Extended 3-Pore Model.

Carl M Öberg1, Bengt Rippe2

  • 1Lund University, Skåne University Hospital, Clinical Sciences Lund, Department of Nephrology, Lund, Sweden.

Kidney International Reports
|December 23, 2017
PubMed
Summary
This summary is machine-generated.

Optimizing automated peritoneal dialysis (APD) with a 3-pore model (TPM) shows higher dialysate flow rates improve middle-molecule clearance. Reduced glucose absorption is possible with optimized APD regimens.

Keywords:
3-pore modelPD prescriptionautomated peritoneal dialysisdialysis efficiencyurea kinetics

More Related Videos

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

16.1K
An Open-Source Normothermic Perfusion System Designed for Research Scientists
11:23

An Open-Source Normothermic Perfusion System Designed for Research Scientists

Published on: July 18, 2025

1.2K

Related Experiment Videos

Last Updated: Feb 16, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

3.3K
Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

16.1K
An Open-Source Normothermic Perfusion System Designed for Research Scientists
11:23

An Open-Source Normothermic Perfusion System Designed for Research Scientists

Published on: July 18, 2025

1.2K

Area of Science:

  • Nephrology
  • Biomedical Engineering
  • Mathematical Modeling

Background:

  • Automated peritoneal dialysis (APD) requires optimization for fluid (UF) and solute transport, as well as glucose absorption.
  • The 3-pore model (TPM) is an established framework for simulating peritoneal dialysis.
  • This study extends the TPM to investigate APD optimization strategies.

Purpose of the Study:

  • To optimize automated peritoneal dialysis (APD) using an extended 3-pore model (TPM).
  • To evaluate the impact of dialysate flow rate (DFR), glucose concentration, and peritoneal transport type on UF, small/middle-molecule clearance, and glucose absorption.
  • To identify optimized APD regimens for reduced glucose absorption.

Main Methods:

  • Simulations were conducted using intermittent APD (IPD) and tidal APD (TPD) scenarios.
  • TPD simulations varied tidal volumes (0.5-1.5 L) and DFRs across different glucose concentrations (1.36-3.86%) and peritoneal transport types (slow, average, fast).
  • Solute clearance and UF were modeled throughout the entire dwell period.

Main Results:

  • Dialysate flow rates (DFR) above ~3 L/h offered diminishing returns for UF and small-solute transport but enhanced middle-molecule clearance.
  • Significant reductions (>20%) in glucose absorption were predicted using higher DFRs and optimized bi-modal APD regimens.
  • Bi-modal regimens alternated glucose-free and glucose-containing solutions.

Conclusions:

  • Optimized APD regimens, including bi-modal strategies, show potential for significantly reducing glucose absorption.
  • Further clinical research is necessary to confirm the feasibility and safety of these proposed APD regimens.